VRS
DNLI icon

Virginia Retirement Systems’s Denali Therapeutics DNLI Stock Holding History

Virginia Retirement Systems’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
+14,300
New +$294K ﹤0.01% 1067
2023
Q3 		$239K Buy
11,600
+1,200
+12% +$30.4K ﹤0.01% 849
2023
Q2 		$307K Sell
10,400
-3,300
-24% -$92.8K ﹤0.01% 834
2023
Q1 		$316K Buy
13,700
+1,000
+8% +$27.5K ﹤0.01% 863
2022
Q4 		$353K Sell
12,700
-300
-2% -$8.93K ﹤0.01% 921
2022
Q3 		$399K Buy
+13,000
New +$423K ﹤0.01% 864
2022
Q1 		$470K Sell
14,600
-11,100
-43% -$382K ﹤0.01% 864
2021
Q4 		$1.15M Sell
25,700
-2,900
-10% -$137K 0.01% 626
2021
Q3 		$1.44M Buy
28,600
+6,400
+29% +$361K 0.01% 504
2021
Q2 		$1.74M Buy
22,200
+1,600
+8% +$99K 0.02% 468
2021
Q1 		$1.18M Buy
20,600
+14,800
+255% +$991K 0.01% 599
2020
Q4 		$486K Sell
5,800
-8,100
-58% -$490K 0.01% 851
2020
Q3 		$498K Buy
+13,900
New +$419K 0.01% 772

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's DNLI Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 14,300 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #1067 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in DNLI as recently as Q3 2023.

Virginia Retirement Systems first reported a position in DNLI in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.74M in Q2 2021. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Virginia Retirement Systems held 14,300 shares of Denali Therapeutics worth $368K as of Q2 2026.
  • Denali Therapeutics was a new Virginia Retirement Systems position in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1067 holding.
  • Virginia Retirement Systems first reported a position in Denali Therapeutics in Q3 2020 and has held it in 13 quarters since.
  • Virginia Retirement Systems's Denali Therapeutics position peaked at $1.74M in Q2 2021.
  • 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.